Amedisys Clinical Programs Team Achieves National Readmissions Prevention Collaborative (NRPC) Certification
BATON ROUGE, La., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice, and personal care companies, today announces that their clinical programs team has completed the National Readmission Prevention Collaborative (NRPC) certification program. The certification program provides deeper training and examination on how to appropriately address readmission issues in local communities.
The certification was completed by the Amedisys clinical programs team responsible for the development and delivery of clinically distinct home healthcare programs, including Amedisys’ two newest programs aimed at chronic disease management for Congestive Heart Failure and Chronic Obstructive Pulmonary Disease (COPD) – two conditions responsible for the majority of hospital readmissions. Amedisys is one of the first home care organizations to receive this prestigious honor held in high regard by leading acute hospitals that are being penalized if patients are readmitted unnecessarily to the hospital.
“The Amedisys clinical programs team is proud to become certified by NRPC. Our patients, wherever they may live, deserve the best care possible to avoid unnecessary hospitalizations,” said Amedisys Vice President of Clinical Programs and Innovation Shannon Abbott.
“As an organization, we are committed to empowering our patients, caregivers, clinicians and provider partners through clinically-distinct programs focused on our most frail population to improve outcomes and quality of life,” stated Amedisys Chief Clinical Officer Susan Sender.
Amedisys’ commitment to clinical quality can be seen in its Quality of Patient Care Star rating of 4.13, 3.25% above the national average, as reported by the Centers for Medicare & Medicaid Services (CMS).
“The NRPC certification is quite an accomplishment for the Amedisys clinical team, as it requires extensive knowledge of the healthcare sector as directed in the Affordable Care Act,” said Josh Luke, Founder, and President of the National Readmission Prevention Collaborative.
The certification process includes research, article reviews, a project submission, and exam. More information on the certification can be found at www.NationalReadmissionPrevention.com.
For more information on how Amedisys can help you or your loved one, click here.
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 16,000 employees, in 421 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 385,000 patients in need every year. For more information about the Company, please visit www.amedisys.com.
CONTACT: Contact: Kendra Kimmons Vice President of Marketing & Communications 225-299-3708 firstname.lastname@example.org
News Provided by GlobeNewswire
© 2017 GlobeNewswire, Inc. All Rights Reserved